-
Entity
-
Individual
-
Location
-
C/O Axovant Sciences, Inc., 320 West 37 Th Street, 5 Th Floor, New York, New York
-
Summary
-
The estimated net worth of Kathryn E. Falberg is at least $29 M dollars as of June 7, 2024. Kathryn E. Falberg is the Director of Trade Desk, Inc. and owns shares of Trade Desk, Inc. (TTD) stock worth about $25.9 M. Kathryn E. Falberg is the Director of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $2.76 M. Kathryn E. Falberg is the Director of Nuvation Bio Inc. and owns shares of Nuvation Bio Inc. (NUVB) stock worth about $340 K.